Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

Radiation-induced esophagitis exacerbated by everolimus.

Miura Y, Suyama K, Shimomura A, Miyakawa J, Kobayashi H, Uki A, Okaneya T, Takano T.

Case Rep Oncol. 2013 Jun 15;6(2):320-4. doi: 10.1159/000353309. Print 2013 May.

PMID:
23898276
[PubMed]
Free PMC Article
3.

Acute cholecystitis in a patient with metastatic renal cell carcinoma treated with everolimus.

Cetin B, Coskun U, Yildiz R, Buyukberber S, Baykara M, Benekli M.

J Oncol Pharm Pract. 2011 Sep;17(3):274-8. doi: 10.1177/1078155210363317. Epub 2010 Mar 9.

PMID:
20215482
[PubMed - indexed for MEDLINE]
4.

Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC).

Shahani R, Kwan KG, Kapoor A.

Drug Healthc Patient Saf. 2010;2:85-91. Epub 2010 Jun 28.

PMID:
21701620
[PubMed]
Free PMC Article
5.

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer.

Huijts CM, Santegoets SJ, van den Eertwegh AJ, Pijpers LS, Haanen JB, de Gruijl TD, Verheul HM, van der Vliet HJ.

BMC Cancer. 2011 Nov 30;11:505. doi: 10.1186/1471-2407-11-505.

PMID:
22129044
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer.

Amato RJ, Jac J, Giessinger S, Saxena S, Willis JP.

Cancer. 2009 Jun 1;115(11):2438-46. doi: 10.1002/cncr.24280.

PMID:
19306412
[PubMed - indexed for MEDLINE]
Free Article
7.

Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancer.

Manegold PC, Paringer C, Kulka U, Krimmel K, Eichhorn ME, Wilkowski R, Jauch KW, Guba M, Bruns CJ.

Clin Cancer Res. 2008 Feb 1;14(3):892-900. doi: 10.1158/1078-0432.CCR-07-0955.

PMID:
18245553
[PubMed - indexed for MEDLINE]
Free Article
8.

Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinoma.

Hadj JO, Braven RD, Tillier C, Schrijver HM, Verheul HM, VAN DER Vliet HJ.

Oncol Lett. 2012 Jun;3(6):1293-1296. Epub 2012 Mar 16.

PMID:
22783436
[PubMed]
Free PMC Article
9.

[Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].

Jeremić B.

Srp Arh Celok Lek. 1996 May-Jun;124(5-6):131-4. Serbian.

PMID:
9102832
[PubMed - indexed for MEDLINE]
10.

Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors.

Chan HY, Grossman AB, Bukowski RM.

Adv Ther. 2010 Aug;27(8):495-511. doi: 10.1007/s12325-010-0045-2. Epub 2010 Jul 8. Review.

PMID:
20623346
[PubMed - indexed for MEDLINE]
11.

Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.

Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D, Yeung C, Curran W.

Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-89-S12-95.

PMID:
9331129
[PubMed - indexed for MEDLINE]
12.

Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer.

Mauceri HJ, Sutton HG, Darga TE, Kocherginsky M, Kochanski J, Weichselbaum RR, Vokes EE.

Oncol Rep. 2012 May;27(5):1625-9. doi: 10.3892/or.2012.1666. Epub 2012 Jan 27.

PMID:
22294050
[PubMed - indexed for MEDLINE]
13.

Pulsed reduced dose-rate radiotherapy as re-irradiation for brain metastasis in a patient with lung squamous-celled carcinoma.

Li GH, Liu Y, Tang JL, Zhang D, Zhou P, Yang DQ, Ma CK.

Jpn J Clin Oncol. 2012 Sep;42(9):856-60. doi: 10.1093/jjco/hys091. Epub 2012 Jun 13.

PMID:
22701036
[PubMed - indexed for MEDLINE]
Free Article
14.

Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.

Yee KW, Zeng Z, Konopleva M, Verstovsek S, Ravandi F, Ferrajoli A, Thomas D, Wierda W, Apostolidou E, Albitar M, O'Brien S, Andreeff M, Giles FJ.

Clin Cancer Res. 2006 Sep 1;12(17):5165-73.

PMID:
16951235
[PubMed - indexed for MEDLINE]
Free Article
15.

Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.

Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K.

Jpn J Clin Oncol. 1994 Oct;24(5):275-81.

PMID:
7967106
[PubMed - indexed for MEDLINE]
16.

Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma.

Porta C, Osanto S, Ravaud A, Climent MA, Vaishampayan U, White DA, Creel P, Dickow B, Fischer P, Gornell SS, Meloni F, Motzer RJ.

Eur J Cancer. 2011 Jun;47(9):1287-98. doi: 10.1016/j.ejca.2011.02.014. Epub 2011 Apr 8. Review.

PMID:
21481584
[PubMed - indexed for MEDLINE]
17.

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.

Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Grünwald V, Thompson JA, Figlin RA, Hollaender N, Urbanowitz G, Berg WJ, Kay A, Lebwohl D, Ravaud A; RECORD-1 Study Group.

Lancet. 2008 Aug 9;372(9637):449-56. doi: 10.1016/S0140-6736(08)61039-9. Epub 2008 Jul 22.

PMID:
18653228
[PubMed - indexed for MEDLINE]
18.

Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy.

Werner-Wasik M, Pequignot E, Leeper D, Hauck W, Curran W.

Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):689-96.

PMID:
11020565
[PubMed - indexed for MEDLINE]
19.

Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.

Singh AK, Lockett MA, Bradley JD.

Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2):337-41.

PMID:
12527046
[PubMed - indexed for MEDLINE]
20.

Hepatitis B reactivation related to everolimus.

Sezgin Göksu S, Bilal S, Coşkun HŞ.

World J Hepatol. 2013 Jan 27;5(1):43-5. doi: 10.4254/wjh.v5.i1.43.

PMID:
23383366
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk